Healthcare Today Montana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Montana.

Press releases published on August 5, 2026

1 hours ago

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Indeterminate GlobeNewswire

1 hours ago

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Indeterminate GlobeNewswire

1 hours ago

Nordic expands global team with new delivery capabilities to accelerate healthcare AI, analytics, managed services, and Epic support

Indeterminate GlobeNewswire

1 hours ago

ImageneBio Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

1 hours ago

UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

Indeterminate GlobeNewswire

1 hours ago

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Indeterminate GlobeNewswire

1 hours ago

Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

Indeterminate GlobeNewswire

1 hours ago

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire

2 hours ago

Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

Indeterminate GlobeNewswire

2 hours ago

Kura Oncology to Report Second Quarter Financial Results

Indeterminate GlobeNewswire

2 hours ago

CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

2 hours ago

Medline Reports Second Quarter and First Six Months 2026 Results

Indeterminate GlobeNewswire

2 hours ago

BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer

Indeterminate GlobeNewswire

2 hours ago

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

2 hours ago

Palvella Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

2 hours ago

Bioventus Reports Second Quarter Financial Results

Indeterminate GlobeNewswire

2 hours ago

Kane Biotech Announces Engagement of DNA Advisors

Indeterminate GlobeNewswire

2 hours ago

Applied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial

Indeterminate GlobeNewswire

2 hours ago

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

Indeterminate GlobeNewswire

2 hours ago

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Indeterminate GlobeNewswire